Literature DB >> 19199792

Quassinoid inhibition of AP-1 function does not correlate with cytotoxicity or protein synthesis inhibition.

John A Beutler1, Moon-Il Kang, Francis Robert, Jason A Clement, Jerry Pelletier, Nancy H Colburn, Tawnya C McKee, Ekaterina Goncharova, James B McMahon, Curtis J Henrich.   

Abstract

Several quassinoids were identified in a high-throughput screening assay as inhibitors of the transcription factor AP-1. Further biological characterization revealed that while their effect was not specific to AP-1, protein synthesis inhibition and cell growth assays were inconsistent with a mechanism of simple protein synthesis inhibition. Numerous plant extracts from the plant family Simaroubaceae were also identified in the same screen; bioassay-guided fractionation of one extract (Ailanthus triphylla) yielded two known quassinoids, ailanthinone (3) and glaucarubinone (4), which were also identified in the pure compound screening procedure.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19199792      PMCID: PMC2837105          DOI: 10.1021/np800732n

Source DB:  PubMed          Journal:  J Nat Prod        ISSN: 0163-3864            Impact factor:   4.050


  24 in total

1.  Quassinoids can induce mitochondrial membrane depolarisation and caspase 3 activation in human cells.

Authors:  A Rosati; E Quaranta; M Ammirante; M C Turco; A Leone; V De Feo
Journal:  Cell Death Differ       Date:  2004-12       Impact factor: 15.828

2.  Structure-activity relationships of quassinoids for eukaryotic protein synthesis.

Authors:  Narihiko Fukamiya; Kuo-Hsiung Lee; Ilias Muhammad; Chihiro Murakami; Masayohis Okano; Isabelle Harvey; Jerry Pelletier
Journal:  Cancer Lett       Date:  2005-03-18       Impact factor: 8.679

3.  A high-throughput cell-based assay to identify specific inhibitors of transcription factor AP-1.

Authors:  Katie M Ruocco; Ekaterina I Goncharova; Matthew R Young; Nancy H Colburn; James B McMahon; Curtis J Henrich
Journal:  J Biomol Screen       Date:  2006-12-14

4.  Mode of action of the anticancer quassinoids--inhibition of the plasma membrane NADH oxidase.

Authors:  D J Morré; P A Grieco; D M Morré
Journal:  Life Sci       Date:  1998       Impact factor: 5.037

Review 5.  NF-kappaB in cancer: from innocent bystander to major culprit.

Authors:  Michael Karin; Yixue Cao; Florian R Greten; Zhi-Wei Li
Journal:  Nat Rev Cancer       Date:  2002-04       Impact factor: 60.716

6.  Siamenol, a new carbazole alkaloid from Murraya siamensis.

Authors:  K M Meragelman; T C McKee; M R Boyd
Journal:  J Nat Prod       Date:  2000-03       Impact factor: 4.050

7.  Multiple myeloma regression mediated by bruceantin.

Authors:  Muriel Cuendet; Konstantin Christov; Daniel D Lantvit; Yunfan Deng; Samad Hedayat; Lawrence Helson; James D McChesney; John M Pezzuto
Journal:  Clin Cancer Res       Date:  2004-02-01       Impact factor: 12.531

8.  Cytotoxic quassinoids from Simaba cedron.

Authors:  A Ozeki; Y Hitotsuyanagi; E Hashimoto; H Itokawa; K Takeya; S de Mello Alves
Journal:  J Nat Prod       Date:  1998-06-26       Impact factor: 4.050

Review 9.  Promising molecular targets for cancer prevention: AP-1, NF-kappa B and Pdcd4.

Authors:  Matthew R Young; Hsin-Sheng Yang; Nancy H Colburn
Journal:  Trends Mol Med       Date:  2003-01       Impact factor: 11.951

10.  AP-1, NF-kappa-B, and ERK activation thresholds for promotion of neoplastic transformation in the mouse epidermal JB6 model.

Authors:  Kazumi Suzukawa; Thomas J Weber; Nancy H Colburn
Journal:  Environ Health Perspect       Date:  2002-09       Impact factor: 9.031

View more
  12 in total

1.  Nothospondin, a new AP-1 inhibitory quassinoid from the Cameroonian plant Nothospondias staudtii.

Authors:  Thushara Diyabalanage; Ranjala Ratnayake; Jennifer A Wilson; Curtis J Henrich; John A Beutler; Nancy H Colburn; James B McMahon; Kirk R Gustafson
Journal:  Bioorg Med Chem Lett       Date:  2011-06-17       Impact factor: 2.823

2.  Compounds from Simarouba berteroana which inhibit proliferation of NF1-defective cancer cells.

Authors:  Krishna P Devkota; Jennifer A Wilson; Curtis J Henrich; James B McMahon; Karlyne M Reilly; John A Beutler
Journal:  Phytochem Lett       Date:  2014-02-01       Impact factor: 1.679

3.  Glaucarubinone inhibits colorectal cancer growth by suppression of hypoxia-inducible factor 1α and β-catenin via a p-21 activated kinase 1-dependent pathway.

Authors:  Nhi Huynh; John A Beutler; Arthur Shulkes; Graham S Baldwin; Hong He
Journal:  Biochim Biophys Acta       Date:  2014-10-22

4.  Antimalarial activity of simalikalactone E, a new quassinoid from Quassia amara L. (Simaroubaceae).

Authors:  N Cachet; F Hoakwie; S Bertani; G Bourdy; E Deharo; D Stien; E Houel; H Gornitzka; J Fillaux; S Chevalley; A Valentin; V Jullian
Journal:  Antimicrob Agents Chemother       Date:  2009-08-10       Impact factor: 5.191

5.  A harmine-derived beta-carboline displays anti-cancer effects in vitro by targeting protein synthesis.

Authors:  Annelise Carvalho; Jennifer Chu; Céline Meinguet; Robert Kiss; Guy Vandenbussche; Bernard Masereel; Johan Wouters; Alexander Kornienko; Jerry Pelletier; Véronique Mathieu
Journal:  Eur J Pharmacol       Date:  2017-03-18       Impact factor: 4.432

6.  Glaucarubinone and gemcitabine synergistically reduce pancreatic cancer growth via down-regulation of P21-activated kinases.

Authors:  Dannel Yeo; Nhi Huynh; John A Beutler; Christopher Christophi; Arthur Shulkes; Graham S Baldwin; Mehrdad Nikfarjam; Hong He
Journal:  Cancer Lett       Date:  2014-01-31       Impact factor: 8.679

7.  Development of Potential Antitumor Agents from the Scaffolds of Plant-Derived Terpenoid Lactones.

Authors:  Yulin Ren; A Douglas Kinghorn
Journal:  J Med Chem       Date:  2020-12-08       Impact factor: 7.446

8.  Role of quassinoids as potential antimalarial agents: An in silico approach.

Authors:  Shailima Rampogu
Journal:  Anc Sci Life       Date:  2015 Oct-Dec

9.  Glaucarubinone sensitizes KB cells to paclitaxel by inhibiting ABC transporters via ROS-dependent and p53-mediated activation of apoptotic signaling pathways.

Authors:  Subburayan Karthikeyan; Sugeerappa Laxmanappa Hoti; Yasin Nazeer; Harsha Vasudev Hegde
Journal:  Oncotarget       Date:  2016-07-05

10.  Small molecule inhibitors targeting activator protein 1 (AP-1).

Authors:  Na Ye; Ye Ding; Christopher Wild; Qiang Shen; Jia Zhou
Journal:  J Med Chem       Date:  2014-05-27       Impact factor: 8.039

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.